During the past decade, University Alabama Hospital Neurology conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "University Alabama Hospital Neurology" are "Parkinson's Disease" (2 trials). Many other conditions were trialed in "University Alabama Hospital Neurology" in a lesser frequency.

Most popular intervention types in "University Alabama Hospital Neurology" are "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "Accordion Pill™ Carbidopa/Levodopa" (2 trials), "Placebo -AP-CD/LD" (1 trials), "Placebo- Sinemet" (1 trials) and "Sinemet®" (1 trials). Other intervention names were less common.

The vast majority of trials in "University Alabama Hospital Neurology" are 2 trials for "All" genders.

Currently, there are NaN active trials in "University Alabama Hospital Neurology". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in University Alabama Hospital Neurology, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in University Alabama Hospital Neurology, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".